Global Focal Segmental Glomerulosclerosis (FSGS) Market Growth 2022-2028
- LP 4924696
- 95 Pages
- March 2022
- Medical Devices
The United States Focal Segmental Glomerulosclerosis (FSGS) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Focal Segmental Glomerulosclerosis (FSGS) market, reaching US$ million by the year 2028. As for the Europe Focal Segmental Glomerulosclerosis (FSGS) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Focal Segmental Glomerulosclerosis (FSGS) players cover Variant Pharmaceuticals, ChemoCentryx, Retrophin, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Focal Segmental Glomerulosclerosis (FSGS) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diagnosis (Kidney Biopsy and Creatine Test)
Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Variant Pharmaceuticals
ChemoCentryx
Retrophin
Novartis
Pfizer
AstraZeneca
Sanofi
GlaxoSmithKline
Teva Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Focal Segmental Glomerulosclerosis (FSGS) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Focal Segmental Glomerulosclerosis (FSGS) by Country/Region, 2017, 2022 & 2028
2.2 Focal Segmental Glomerulosclerosis (FSGS) Segment by Type
2.2.1 Diagnosis (Kidney Biopsy and Creatine Test)
2.2.2 Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
2.3 Focal Segmental Glomerulosclerosis (FSGS) Sales by Type
2.3.1 Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type (2017-2022)
2.3.2 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Focal Segmental Glomerulosclerosis (FSGS) Sale Price by Type (2017-2022)
2.4 Focal Segmental Glomerulosclerosis (FSGS) Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Specialty Clinics
2.5 Focal Segmental Glomerulosclerosis (FSGS) Sales by Application
2.5.1 Global Focal Segmental Glomerulosclerosis (FSGS) Sale Market Share by Application (2017-2022)
2.5.2 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Focal Segmental Glomerulosclerosis (FSGS) Sale Price by Application (2017-2022)
3 Global Focal Segmental Glomerulosclerosis (FSGS) by Company
3.1 Global Focal Segmental Glomerulosclerosis (FSGS) Breakdown Data by Company
3.1.1 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Sales by Company (2020-2022)
3.1.2 Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Company (2020-2022)
3.2 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Revenue by Company (2020-2022)
3.2.1 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Company (2020-2022)
3.2.2 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Company (2020-2022)
3.3 Global Focal Segmental Glomerulosclerosis (FSGS) Sale Price by Company
3.4 Key Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Product Location Distribution
3.4.2 Players Focal Segmental Glomerulosclerosis (FSGS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Focal Segmental Glomerulosclerosis (FSGS) by Geographic Region
4.1 World Historic Focal Segmental Glomerulosclerosis (FSGS) Market Size by Geographic Region (2017-2022)
4.1.1 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Revenue by Geographic Region
4.2 World Historic Focal Segmental Glomerulosclerosis (FSGS) Market Size by Country/Region (2017-2022)
4.2.1 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Revenue by Country/Region
4.3 Americas Focal Segmental Glomerulosclerosis (FSGS) Sales Growth
4.4 APAC Focal Segmental Glomerulosclerosis (FSGS) Sales Growth
4.5 Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Growth
4.6 Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Growth
5 Americas
5.1 Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Country
5.1.1 Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Country (2017-2022)
5.1.2 Americas Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country (2017-2022)
5.2 Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Type
5.3 Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Region
6.1.1 APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Region (2017-2022)
6.1.2 APAC Focal Segmental Glomerulosclerosis (FSGS) Revenue by Region (2017-2022)
6.2 APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Type
6.3 APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Focal Segmental Glomerulosclerosis (FSGS) by Country
7.1.1 Europe Focal Segmental Glomerulosclerosis (FSGS) Sales by Country (2017-2022)
7.1.2 Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country (2017-2022)
7.2 Europe Focal Segmental Glomerulosclerosis (FSGS) Sales by Type
7.3 Europe Focal Segmental Glomerulosclerosis (FSGS) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) by Country
8.1.1 Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country (2017-2022)
8.2 Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales by Type
8.3 Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Focal Segmental Glomerulosclerosis (FSGS)
10.3 Manufacturing Process Analysis of Focal Segmental Glomerulosclerosis (FSGS)
10.4 Industry Chain Structure of Focal Segmental Glomerulosclerosis (FSGS)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Focal Segmental Glomerulosclerosis (FSGS) Distributors
11.3 Focal Segmental Glomerulosclerosis (FSGS) Customer
12 World Forecast Review for Focal Segmental Glomerulosclerosis (FSGS) by Geographic Region
12.1 Global Focal Segmental Glomerulosclerosis (FSGS) Market Size Forecast by Region
12.1.1 Global Focal Segmental Glomerulosclerosis (FSGS) Forecast by Region (2023-2028)
12.1.2 Global Focal Segmental Glomerulosclerosis (FSGS) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Focal Segmental Glomerulosclerosis (FSGS) Forecast by Type
12.7 Global Focal Segmental Glomerulosclerosis (FSGS) Forecast by Application
13 Key Players Analysis
13.1 Variant Pharmaceuticals
13.1.1 Variant Pharmaceuticals Company Information
13.1.2 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.1.3 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Variant Pharmaceuticals Main Business Overview
13.1.5 Variant Pharmaceuticals Latest Developments
13.2 ChemoCentryx
13.2.1 ChemoCentryx Company Information
13.2.2 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.2.3 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ChemoCentryx Main Business Overview
13.2.5 ChemoCentryx Latest Developments
13.3 Retrophin
13.3.1 Retrophin Company Information
13.3.2 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.3.3 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Retrophin Main Business Overview
13.3.5 Retrophin Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.4.3 Novartis Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.5.3 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.6.3 AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.7.3 Sanofi Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Information
13.8.2 GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.8.3 GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GlaxoSmithKline Main Business Overview
13.8.5 GlaxoSmithKline Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Product Offered
13.9.3 Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Focal Segmental Glomerulosclerosis (FSGS) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Focal Segmental Glomerulosclerosis (FSGS) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diagnosis (Kidney Biopsy and Creatine Test)
Table 4. Major Players of Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
Table 5. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Type (2017-2022) & (Kg)
Table 6. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type (2017-2022)
Table 7. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Type (2017-2022)
Table 9. Global Focal Segmental Glomerulosclerosis (FSGS) Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Application (2017-2022) & (Kg)
Table 11. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Application (2017-2022)
Table 12. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Application (2017-2022)
Table 13. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Application (2017-2022)
Table 14. Global Focal Segmental Glomerulosclerosis (FSGS) Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Company (2020-2022) & (Kg)
Table 16. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Company (2020-2022)
Table 17. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Company (2020-2022)
Table 19. Global Focal Segmental Glomerulosclerosis (FSGS) Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Producing Area Distribution and Sales Area
Table 21. Players Focal Segmental Glomerulosclerosis (FSGS) Products Offered
Table 22. Focal Segmental Glomerulosclerosis (FSGS) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Country (2017-2022) & (Kg)
Table 34. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country (2017-2022)
Table 35. Americas Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country (2017-2022)
Table 37. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Type (2017-2022) & (Kg)
Table 38. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type (2017-2022)
Table 39. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales by Application (2017-2022) & (Kg)
Table 40. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Application (2017-2022)
Table 41. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Region (2017-2022) & (Kg)
Table 42. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Region (2017-2022)
Table 43. APAC Focal Segmental Glomerulosclerosis (FSGS) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Region (2017-2022)
Table 45. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Type (2017-2022) & (Kg)
Table 46. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type (2017-2022)
Table 47. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales by Application (2017-2022) & (Kg)
Table 48. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Application (2017-2022)
Table 49. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales by Country (2017-2022) & (Kg)
Table 50. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country (2017-2022)
Table 51. Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country (2017-2022)
Table 53. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales by Type (2017-2022) & (Kg)
Table 54. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type (2017-2022)
Table 55. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales by Application (2017-2022) & (Kg)
Table 56. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Focal Segmental Glomerulosclerosis (FSGS)
Table 66. Key Market Challenges & Risks of Focal Segmental Glomerulosclerosis (FSGS)
Table 67. Key Industry Trends of Focal Segmental Glomerulosclerosis (FSGS)
Table 68. Focal Segmental Glomerulosclerosis (FSGS) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Focal Segmental Glomerulosclerosis (FSGS) Distributors List
Table 71. Focal Segmental Glomerulosclerosis (FSGS) Customer List
Table 72. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Forecast by Region
Table 74. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Variant Pharmaceuticals Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 93. Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 94. Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. Variant Pharmaceuticals Main Business
Table 96. Variant Pharmaceuticals Latest Developments
Table 97. ChemoCentryx Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 98. ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 99. ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. ChemoCentryx Main Business
Table 101. ChemoCentryx Latest Developments
Table 102. Retrophin Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 103. Retrophin Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 104. Retrophin Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Retrophin Main Business
Table 106. Retrophin Latest Developments
Table 107. Novartis Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 108. Novartis Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 109. Novartis Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Novartis Main Business
Table 111. Novartis Latest Developments
Table 112. Pfizer Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 114. Pfizer Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. AstraZeneca Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 118. AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 119. AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. AstraZeneca Main Business
Table 121. AstraZeneca Latest Developments
Table 122. Sanofi Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 124. Sanofi Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Sanofi Main Business
Table 126. Sanofi Latest Developments
Table 127. GlaxoSmithKline Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 128. GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 129. GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. GlaxoSmithKline Main Business
Table 131. GlaxoSmithKline Latest Developments
Table 132. Teva Pharmaceutical Basic Information, Focal Segmental Glomerulosclerosis (FSGS) Manufacturing Base, Sales Area and Its Competitors
Table 133. Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Product Offered
Table 134. Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 135. Teva Pharmaceutical Main Business
Table 136. Teva Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Focal Segmental Glomerulosclerosis (FSGS)
Figure 2. Focal Segmental Glomerulosclerosis (FSGS) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Focal Segmental Glomerulosclerosis (FSGS) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diagnosis (Kidney Biopsy and Creatine Test)
Figure 10. Product Picture of Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
Figure 11. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Type in 2021
Figure 12. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Type (2017-2022)
Figure 13. Focal Segmental Glomerulosclerosis (FSGS) Consumed in Hospitals
Figure 14. Global Focal Segmental Glomerulosclerosis (FSGS) Market: Hospitals (2017-2022) & (Kg)
Figure 15. Focal Segmental Glomerulosclerosis (FSGS) Consumed in Ambulatory Surgical Centers
Figure 16. Global Focal Segmental Glomerulosclerosis (FSGS) Market: Ambulatory Surgical Centers (2017-2022) & (Kg)
Figure 17. Focal Segmental Glomerulosclerosis (FSGS) Consumed in Specialty Clinics
Figure 18. Global Focal Segmental Glomerulosclerosis (FSGS) Market: Specialty Clinics (2017-2022) & (Kg)
Figure 19. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Application (2017-2022)
Figure 20. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Application in 2021
Figure 21. Focal Segmental Glomerulosclerosis (FSGS) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Company in 2021
Figure 23. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Region (2017-2022)
Figure 26. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales 2017-2022 (Kg)
Figure 28. Americas Focal Segmental Glomerulosclerosis (FSGS) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales 2017-2022 (Kg)
Figure 30. APAC Focal Segmental Glomerulosclerosis (FSGS) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales 2017-2022 (Kg)
Figure 32. Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales 2017-2022 (Kg)
Figure 34. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country in 2021
Figure 36. Americas Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country in 2021
Figure 37. United States Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Region in 2021
Figure 42. APAC Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Regions in 2021
Figure 43. China Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country in 2021
Figure 50. Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country in 2021
Figure 51. Germany Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share by Country in 2021
Figure 58. Egypt Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Focal Segmental Glomerulosclerosis (FSGS) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Focal Segmental Glomerulosclerosis (FSGS) in 2021
Figure 64. Manufacturing Process Analysis of Focal Segmental Glomerulosclerosis (FSGS)
Figure 65. Industry Chain Structure of Focal Segmental Glomerulosclerosis (FSGS)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
